For citations:
Zyryanov S.K., Kalashnikova M.F., D.Yu., Afanasyeva E.V. Pharmacoeconomics of dapagliflozin in patients with type 2 diabetes mellitus with inadequate glycemic control. Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice. 2014;(3):4-16. (In Russ.)